Pacira (PCRX) SVP has 3,187 shares withheld for tax obligations

Rhea-AI Filing Summary

Pacira BioSciences Senior Vice President of Finance Lauren Riker reported a routine tax-related share disposition. On a restricted stock unit vesting, 3,187 shares of common stock were withheld by the company to cover tax obligations at $22.32 per share. After this withholding, Riker directly holds 68,399.242 shares of Pacira common stock, indicating the transaction was a standard compensation-related event rather than an open-market sale.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider RIKER LAUREN

Role Senior Vice President, Finance

Type	Security	Shares	Price	Value
Tax Withholding	Common Stock	3,187	$22.32	$71K

Holdings After Transaction: Common Stock — 68,399.242 shares (Direct, null)

Footnotes (1)

1. [object Object]

Key Figures

Tax-withheld shares: 3,187 shares Withholding price: $22.32 per share Shares held after transaction: 68,399.242 shares +1 more

4 metrics

Tax-withheld shares 3,187 shares Withheld to cover tax obligations on RSU vesting

Withholding price $22.32 per share Price applied to withheld Pacira common stock

Shares held after transaction 68,399.242 shares Direct Pacira common stock ownership post-transaction

Transaction date 2026-06-03 Date of tax-withholding disposition

Key Terms

restricted stock unit award, tax withholding obligations, tax-withholding disposition

3 terms

restricted stock unit award financial

"upon vesting of a restricted stock unit award"

A restricted stock unit award is a promise by a company to give an employee a specified number of company shares at a future date if certain conditions are met, such as staying with the company or hitting performance goals. For investors, these awards matter because they can increase the total number of shares outstanding when converted, diluting existing holders, and they align employees’ incentives with shareholders’ interests much like giving a rising bonus that becomes real only after conditions are satisfied.

tax withholding obligations financial

"shares withheld by the issuer to cover tax withholding obligations"

tax-withholding disposition financial

"transaction_action: tax-withholding disposition"

A tax-withholding disposition is an event or transaction—such as selling or transferring securities, exercising options, or receiving compensation—that triggers a requirement to hold back part of the payment and remit it to tax authorities. It matters to investors because it reduces the cash they receive immediately and can change the timing and amount of taxable income, like a cashier taking a portion of your sale proceeds to pay taxes before you get the rest.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

RIKER LAUREN

(Last) (First) (Middle)

C/O PACIRA BIOSCIENCES, INC.

2000 SIERRA POINT PARKWAY, SUITE 900

(Street)

BRISBANE CALIFORNIA 94005

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Pacira BioSciences, Inc. [ PCRX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Senior Vice President, Finance

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/03/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	06/03/2026		F		3,187(1)	D	$22.32	68,399.242	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents shares withheld by the issuer to cover tax withholding obligations upon vesting of a restricted stock unit award.

Remarks:

	/s/ Kristen Williams, Attorney-in-Fact	06/05/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did Pacira BioSciences (PCRX) report for Lauren Riker?

Pacira reported that Senior Vice President of Finance Lauren Riker had 3,187 common shares withheld to cover tax obligations upon vesting of a restricted stock unit award. This was a compensation-related, non-market transaction categorized as a tax-withholding disposition.

Was the Pacira (PCRX) insider transaction an open-market sale of shares?

No, the transaction was not an open-market sale. Shares were withheld by Pacira to satisfy tax withholding obligations tied to a restricted stock unit vesting, meaning Riker did not sell shares into the market but had them retained by the issuer for taxes.

How many Pacira (PCRX) shares were involved in Lauren Riker’s tax withholding?

The transaction involved 3,187 shares of Pacira common stock withheld by the issuer. These shares were used to cover tax obligations arising from the vesting of a restricted stock unit award, as described in the Form 4 footnote.

At what price were Lauren Riker’s Pacira (PCRX) shares withheld for taxes?

The withheld shares are reported at a price of $22.32 per Pacira common share. This price is used for the tax-withholding calculation on the restricted stock unit vesting and does not represent an open-market sale executed by the insider.

How many Pacira (PCRX) shares does Lauren Riker hold after the transaction?

Following the tax-withholding disposition, Lauren Riker directly holds 68,399.242 shares of Pacira common stock. This post-transaction balance shows she continues to maintain a significant equity position after the routine tax-related share withholding.

What does the Form 4 footnote say about Pacira (PCRX) shares withheld from Lauren Riker?

The footnote explains that the reported shares represent stock withheld by Pacira to cover tax withholding obligations when a restricted stock unit award vested. This clarifies the transaction as an automatic, compensation-driven event rather than a discretionary trade in the open market.